Reuters

US FDA to review decades-old food preservative in safety overhaul

Feb 10 (Reuters) - The U.S. Food and Drug Administration on Tuesday launched a broad review of a long-used synthetic preservative used in packaged foods, as the agency steps up efforts to reassess ...
BioSpace

Opinion: 2025 Reshaped the FDA. What Will 2026 Hold?

The FDA underwent significant changes during the first year of the second Trump administration, directly affecting business risk and opportunity. Understanding key 2025 trends will be critical to ...
CNBC

U.S. signals crackdown on compounded weight-loss drugs; Hims shares tumble

The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss pill, including restricting access to the drug's ingredients ...
Associated Press

Companies can now claim ‘no artificial colors’ if they add plant-based color to food

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Applications Scientist Anuj Bag mixes coloring ...
CNN

FDA approves natural food dye beetroot red, expands the use of spirulina

As part of the “Make America Healthy Again” movement’s efforts to replace artificial, petroleum-based food dyes with natural ones, the US Food and Drug Administration says it has approved the use of ...
aha.org

FDA issues most serious recall for certain glucose monitor sensors

The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors by Abbott Diabetes Care due to incorrect glucose readings that are ...
FiercePharma

FDA emphasizes drug ingredients, production pledges as it debuts PreCheck manufacturing program

Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to significantly reduce the complexities involved in setting up domestic manufacturing ...
Forbes

As Healthcare AI Changes On The Fly, FDA Reconsiders How To Keep It Safe

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Why the FDA's latest move signals a shift toward lifecycle thinking, not deregulation.
Reuters

US FDA places clinical hold on Regenxbio's rare disease program

Jan 28 (Reuters) - Regenxbio (RGNX.O), opens new tab said on Wednesday the U.S. Food and Drug Administration has placed a clinical hold on two of its experimental gene therapy programs for rare ...
MedPage Today

New COVID Vaccine Limits: Who Is Considered High-Risk?

New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...
medtechdive

FDA guidance eases wearables oversight. But experts have questions about what’s next.

Amid a deregulatory push by the Trump administration, the Food and Drug Administration is scrutinizing its digital health policies. The agency suddenly issued a pair of guidances earlier this month, ...